These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Common occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and in biliary cancers. Laghi L; Orbetegli O; Bianchi P; Zerbi A; Di Carlo V; Boland CR; Malesci A Oncogene; 2002 Jun; 21(27):4301-6. PubMed ID: 12082617 [TBL] [Abstract][Full Text] [Related]
4. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma. Wilentz RE; Chung CH; Sturm PD; Musler A; Sohn TA; Offerhaus GJ; Yeo CJ; Hruban RH; Slebos RJ Cancer; 1998 Jan; 82(1):96-103. PubMed ID: 9428484 [TBL] [Abstract][Full Text] [Related]
5. Neoplasms of the ampulla of vater with concurrent pancreatic intraductal neoplasia: a histological and molecular study. Agoff SN; Crispin DA; Bronner MP; Dail DH; Hawes SE; Haggitt RC Mod Pathol; 2001 Mar; 14(3):139-46. PubMed ID: 11266517 [TBL] [Abstract][Full Text] [Related]
6. Detection of point mutation in K-ras oncogene at codon 12 in pancreatic diseases. Ren YX; Xu GM; Li ZS; Song YG World J Gastroenterol; 2004 Mar; 10(6):881-4. PubMed ID: 15040037 [TBL] [Abstract][Full Text] [Related]
7. K-ras mutations in tissue and stool samples from patients with pancreatic cancer and chronic pancreatitis. Wenger FA; Zieren J; Peter FJ; Jacobi CA; Müller JM Langenbecks Arch Surg; 1999 Apr; 384(2):181-6. PubMed ID: 10328172 [TBL] [Abstract][Full Text] [Related]
8. ras-family gene mutations in neoplasia of the ampulla of Vater. Scarpa A; Zamboni G; Achille A; Capelli P; Bogina G; Iacono C; Serio G; Accolla RS Int J Cancer; 1994 Oct; 59(1):39-42. PubMed ID: 7927901 [TBL] [Abstract][Full Text] [Related]
9. Distinguishing pancreatic carcinoma from other periampullary carcinomas by analysis of mutations in the Kirsten-ras oncogene. Motojima K; Tsunoda T; Kanematsu T; Nagata Y; Urano T; Shiku H Ann Surg; 1991 Dec; 214(6):657-62. PubMed ID: 1741644 [TBL] [Abstract][Full Text] [Related]
10. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis. Moore PS; Orlandini S; Zamboni G; Capelli P; Rigaud G; Falconi M; Bassi C; Lemoine NR; Scarpa A Br J Cancer; 2001 Jan; 84(2):253-62. PubMed ID: 11161385 [TBL] [Abstract][Full Text] [Related]
11. Analysis of K-ras gene mutations in periampullary cancers, gallbladder cancers and cholangiocarcinomas from paraffin-embedded tissue sections. Lee JC; Lin PW; Lin YJ; Lai J; Yang HB; Lai MD J Formos Med Assoc; 1995 Dec; 94(12):719-23. PubMed ID: 8541732 [TBL] [Abstract][Full Text] [Related]
12. Patterns of K-ras codon 12 and 13 mutations found in pancreatic adenocarcinoma of 30 Chinese patients by microdissection, PCR and direct sequencing. Wei S; Liang Z; Gao J; Wu S; Zhu H; Liu H; Liu T J Gastroenterol Hepatol; 2005 Jan; 20(1):67-72. PubMed ID: 15610449 [TBL] [Abstract][Full Text] [Related]
13. Detection of point mutations in the K-ras oncogene at codon 12 in pure pancreatic juice for diagnosis of pancreatic carcinoma. Kondo H; Sugano K; Fukayama N; Kyogoku A; Nose H; Shimada K; Ohkura H; Ohtsu A; Yoshida S; Shimosato Y Cancer; 1994 Mar; 73(6):1589-94. PubMed ID: 8156485 [TBL] [Abstract][Full Text] [Related]
14. Ki-ras and p53 mutations in pancreatic ductal adenocarcinoma. Rall CJ; Yan YX; Graeme-Cook F; Beauchamp R; Yandell DW; Povoski SP; Rustgi AK Pancreas; 1996 Jan; 12(1):10-7. PubMed ID: 8927612 [TBL] [Abstract][Full Text] [Related]
15. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602 [TBL] [Abstract][Full Text] [Related]
16. Frequent somatic mutations of the APC and p53 genes in sporadic ampullary carcinomas. Imai Y; Oda H; Tsurutani N; Nakatsuru Y; Inoue T; Ishikawa T Jpn J Cancer Res; 1997 Sep; 88(9):846-54. PubMed ID: 9369932 [TBL] [Abstract][Full Text] [Related]
17. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium. Lüttges J; Schlehe B; Menke MA; Vogel I; Henne-Bruns D; Klöppel G Cancer; 1999 Apr; 85(8):1703-10. PubMed ID: 10223563 [TBL] [Abstract][Full Text] [Related]
18. Detection of c-Ki-ras gene codon 12 mutations from pancreatic duct brushings in the diagnosis of pancreatic tumours. Van Laethem JL; Vertongen P; Deviere J; Van Rampelbergh J; Rickaert F; Cremer M; Robberecht P Gut; 1995 May; 36(5):781-7. PubMed ID: 7797131 [TBL] [Abstract][Full Text] [Related]
19. Role of the DPC4 tumor suppressor gene in adenocarcinoma of the ampulla of Vater: analysis of 140 cases. McCarthy DM; Hruban RH; Argani P; Howe JR; Conlon KC; Brennan MF; Zahurak M; Wilentz RE; Cameron JL; Yeo CJ; Kern SE; Klimstra DS Mod Pathol; 2003 Mar; 16(3):272-8. PubMed ID: 12640108 [TBL] [Abstract][Full Text] [Related]
20. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Caldas C; Hahn SA; Hruban RH; Redston MS; Yeo CJ; Kern SE Cancer Res; 1994 Jul; 54(13):3568-73. PubMed ID: 8012983 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]